Carboplatin Plus Vincristine in Treating Children With Retinoblastoma

Completed · Phase 2

Conditions studied: Retinoblastoma

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of carboplatin plus vincristine in treating children with retinoblastoma.

Key facts

Study ID

NCT00002794

Run by

St. Jude Children's Research Hospital

People needed

25

Starts

1996-02-01

Expected to finish

2001-06-01

Last updated by the study team

2011-10-04

Who can join

Age: any, up to 10. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Tennessee, Memphis Cancer Center — Memphis, Tennessee, United States
• Saint Jude Children's Research Hospital — Memphis, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.